News
12/5/2017

CRG: Fluorescent marine worms, software for protein binding propensity, and transdifferentiation of leukemic B-cells

CRG: Fluorescent marine worms, software for protein binding propensity, and transdifferentiation of leukemic B-cells


News from CRG


Since many inventions remain unexploited due to the absence of an industry sponsor, or the lack of funding, the CRG established a Proof of Concept: Commercialization Gap Fund (CGF) in an effort to bridge the gap from research to commercialization. Now, three projects have been launched within the CGF.

Applications of the Commercialization Gap Fund (CGF) 2016 edition were evaluated by a committee consisting of two industry experts, two investors, a CRG group leader, and the Technology and Business Development team. From 6 initial applications, the evaluation committee selected 3 applications for funding.

Masha Plyuscheva, at the laboratory of ICREA research professor Fyodor Kondrashov, is leading a project aimed at characterizing newly, potentially fluorescent proteins, which she isolated from a marine parchment worm. ICREA research professor Gian Gaetano Tartaglia and his team, will validate experimentally, the predictive power of a new algorithm to estimate the binding propensity of protein-RNA pairs. And, Thomas Graf and his group will try to establish a potential target pathway upstream a transcription factor, which induces transdifferentiation from leukemic B-cells into neutral, non-tumorgenic macrophages. 

The call for the 2017 CGF is now open. CRG scientists can submit their innovative proposals by October 1st. Please, find more information about this initiative and the 2017 call, here.

More information:
CRG website